we prepared extracts from HeLa cells that had been arrested in prometaphase with nocodazole and then Centriole duplication initiates at the G1-to-S transition released for up to 16 hr. Western blotting revealed that in mammalian cells and is completed during the S and hPlk2 protein was expressed at equal abundance during G2 phases. The localization of a number of protein G1, S, and G2 phases ( Figure 1A ). In contrast, hPlk2 kinases to the centrosome has revealed the imporkinase activity as determined in immunoprecipitates tance of protein phosphorylation in controlling the with ␣-casein as the substrate peaked as cells entered centriole duplication cycle. Here we show that the hu-S phase and decreased again as cells entered G2 phase man Polo-like kinase 2 (Plk2) is activated near the ( Figure 1A) . No significant ␣-casein activity was seen in G1-to-S transition of the cell cycle. Endogenous and control immunoprecipitates with preimmune sera (data overexpressed HA-Plk2 localize with centrosomes, not shown). The activity of hPlk2 appears simultaneously and this interaction is independent of Plk2 kinase acwith cyclin E expression and cyclin E-dependent kinase tivity. In contrast, the kinase activity of Plk2 is required activity, strongly implying that hPlk2 is activated by a for centriole duplication. Overexpression of a kinaseposttranslational mechanism at the onset of S phase. deficient mutant under S-phase arrest blocks centriole Flow cytometry confirmed the synchrony of the samples duplication. Downregulation of endogenous Plk2 with ( Figure 1B) . small hairpin RNAs interferes with the ability to redupliTo study the subcellular localization and function of cate centrioles. Furthermore, centrioles failed to duplihPlk2, we first overexpressed HA-epitope-tagged hPlk2 cate during the cell cycle of human fibroblasts and and HA-hPlk2dn (having a K111R point mutation in the U2OS cells after overexpression of a Plk2 dominantcatalytic domain) in U2OS cells. Whereas hPlk2wt exhibnegative mutant. These results show that Plk2 is a ited strong ␣-casein activity, hPlk2dn was essentially physiological centrosomal protein and that its kinase inactive ( Figure S2 ). Ectopic expression of both Plk2 activity is likely to be required for centriole duplication constructs revealed a pronounced centrosomal stainnear the G1-to-S phase transition.
splicing factor indicates that the centrosome preparainhibit centriole duplication ( [8] [9] [10] and Figure 2C . We suggest that hPlk2dn inhibits centriole duplication by tion is essentially free of nuclear contamination ( Figure  1E , left). Immunofluorescent staining of these preparadisplacing the endogenously active hPlk2 from the centrosome and/or by titrating out a key regulator or subtions with ␣-tubulin, a specific marker of centrioles, revealed a punctate staining of two closely neighbored strate into nonfunctional complexes. Similar results were also obtained when U2OS cells were used instead spots; such staining is characteristic of intact centrosomes and precisely overlapped with that of ␣-tubulin, of CHO cells in transient transfection experiments with hPlk2dn (data not shown). The most straightforward inconfirming that hPlk2 localizes to centrosomes ( Figure  1E , right). No centrosome staining was produced by the terpretation of these results is that centriole duplication must depend on the activity of hPlk2. It was recently corresponding preimmune antibodies ( Figure 1E ). Because hPlk2 kinase is present both in vitro and reported that human Plk1 is also required for centriole duplication in U2OS cells [11] . However, in contrast to in vivo at the centrosome in interphase cells and its kinase activity first appears at the G1/S boundary, we our results with hPlk2dn, we found that the bulk of cells transfected with hPlk1dn contained more than two cenanticipated that hPlk2 might be required for centriole duplication. To test this hypothesis, we first asked trioles per cell ( Figure 2C ), suggesting that hPlk1dn does not significantly interfere with centriole duplication. This whether overexpression of wild-type hPlk2 could lead to an alteration in centrosome number. Immunostaining falls in line with the fact that Plk1 kinase activity is low during interphase but high during mitosis [12] . with ␥-tubulin antibodies revealed that 48 hr after transfection, cells expressing hPlk2 did have noticeably more A recent report indicates that silencing of hPlk2 by RNAi leads to apoptosis in the presence of taxol. This centrosomes than untransfected cells (Figure 2A ). However, although this could be interpreted to mean that effect might be explained by a failure to duplicate centrioles; this failure might lead to sensitization of cells to hPlk2 promotes centriole duplication, it could equally result from hPlk2 interfering with cell cycle progression microtubule inhibitors in mitosis [13] . To further explore a possible role of hPlk2 in centriole duplication, we or cytokinesis. We therefore decided to determine whether the kinase-inactive hPlk2dn could act in a domiasked whether downregulation of endogenous hPlk2 by RNA interference (RNAi) would prevent cells from nant-negative manner to block centriole duplication. One can use DNA synthesis inhibitors to experimentally reduplicating centrioles. To test this, we depleted hPlk2 mRNA in U2OS cells by using vectors that expressed uncouple centriole duplication from DNA replication in certain cell types [7] . For example, CHO cells treated small hairpin RNAs (sh-RNAs) directed against two distinct hPlk2 coding sequences [14] . demonstrates that the block seen for centriole redupli- or GFP alone into human foreskin fibroblasts (Hs68).
Immunofluorescence, Centrosome Preparation,
Immunfluorescence labeling with the centriole-specific Taken together, our data provide the first evidence [20] . Primary antibodies were detected with anti-mouse Alexa 488-that Plk2 kinase is required for centriole duplication. 
